SPARC reports positive results from Phase 3 trial of ocular hypertension treatment Ruchika Sharma16 May 2021 10:00 AM ISTMumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) has recently reported positive top-line results from its Phase 3 trial (CLR_16_33) for...
SPARC issues warrants worth Rs 1,200 crore to promoter Dilip Shanghvi, others Ruchika Sharma14 May 2021 12:31 PM ISTNew Delhi: Sun Pharma Advanced Research Company (SPARC) plans to raise up to Rs 1,200 crore by way of issuing warrants to the company''s promoter...
Sun Pharma Advanced Research Company application for cancer drug Taclantis denied by USFDA Ruchika Sharma24 Feb 2021 1:18 PM ISTNew Delhi: Sun Pharma Advanced Research Company Ltd on Tuesday said the USFDA has ruled against its appeal related to Taclantis, its under...
SPARC investigational drug shows promise in phase 3 trial for treating inflammation, pain related to ocular surgery Ruchika Sharma15 Oct 2020 12:30 PM ISTThe objective of the trial was to assess the efficacy and safety of SDN-037 in clearing the inflammation and pain, the company added.
SPARC, Sun Pharma enter into license agreement for SCD-044, a potential treatment for atopic dermatitis, psoriasis, more Ruchika Sharma29 May 2020 4:25 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd. and Sun Pharmaceutical Industries Ltd. have announced a worldwide licensing agreement on the...
Expect delay in start of royalty from 2 new drugs: SPARC savita thakur thakur1 Jan 2016 12:16 PM ISTNEW DELHI: Sun Pharma Advanced Research Company (SPARC) expects further delay in start of royalty income from its two new drug applications, including...
USFDA rejects Sun Pharma's Anti-Glaucoma Eyedrops Meghna A Singhania2 Aug 2015 11:59 AM ISTIn a setback to Sun Pharma, USFDA yesterday rejected its subsidiary's Sun Pharma Advanced Research Company's Application for its new anti-glaucoma eye...
Sun Pharma Research Div Likely for file new drug application with USFDA Meghna A Singhania31 July 2015 12:29 PM ISTSun Pharma Advanced Research Company likely to file new drug application with FDA, confirms Dilip ShanghviThe research division of Sun...
